Armstrong Excelon Vinyl Asbestos Floor Tile

Product Description

Armstrong Excelon vinyl asbestos floor tile was a widely used commercial and institutional flooring product manufactured by Armstrong World Industries from approximately 1954 through 1980. Sold under the Excelon brand name, these tiles were a staple of mid-twentieth-century construction, appearing in schools, hospitals, government buildings, factories, warehouses, and retail spaces across the United States. The product was marketed as a durable, cost-effective alternative to pure vinyl tile, offering resistance to heavy foot traffic, grease, and moisture — characteristics that made it especially attractive for industrial and commercial environments.

Armstrong World Industries, headquartered in Lancaster, Pennsylvania, was one of the dominant manufacturers in the American flooring industry throughout the postwar decades. The Excelon line represented a significant portion of the company’s commercial tile portfolio during this period. Tiles were typically produced in 9-inch by 9-inch and 12-inch by 12-inch squares, in a range of colors and patterns, and were installed using adhesive compounds that were sometimes also asbestos-containing.

Production of Excelon vinyl asbestos tile ceased by 1980, consistent with the broader industry withdrawal from asbestos-containing building materials that followed growing regulatory scrutiny and the tightening of occupational health standards through the 1970s. The U.S. Environmental Protection Agency’s Asbestos Hazard Emergency Response Act (AHERA) and related regulations later identified vinyl asbestos floor tile as a regulated asbestos-containing building material, establishing abatement protocols that remain in force today.

Asbestos Content

Armstrong Excelon vinyl asbestos floor tile contained chrysotile asbestos, the most commercially prevalent form of asbestos fiber. Chrysotile, sometimes called white asbestos, was incorporated into the tile matrix as a reinforcing and binding agent. Its fine, curly fibers provided tensile strength, dimensional stability, and resistance to heat and chemical degradation — properties that manufacturers relied on to meet the performance demands of commercial flooring applications.

In vinyl asbestos tile formulations of this era, asbestos fiber content typically constituted a significant proportion of the total product composition by weight, with chrysotile fibers bound within a matrix of polyvinyl chloride (PVC) resins, plasticizers, and mineral fillers. When tiles were in an intact, undisturbed condition, the asbestos fibers were largely encapsulated within this matrix. However, the bound state of the fibers did not eliminate hazard in all circumstances — particularly during manufacturing, cutting, sanding, grinding, or demolition activities that mechanically disrupted the tile material.

Litigation records document that Armstrong World Industries was aware of the presence of asbestos in Excelon tiles and that internal and industry-level knowledge about the health hazards of asbestos exposure existed well before the product was withdrawn from the market.

How Workers Were Exposed

Workers across multiple trades and industrial settings encountered Armstrong Excelon vinyl asbestos floor tile in ways that could generate respirable asbestos fiber release. Exposure pathways documented in litigation records fall into several distinct categories related to the product’s lifecycle — from manufacturing through installation and eventual removal.

Manufacturing Exposure: Workers employed at Armstrong production facilities handled raw chrysotile asbestos fiber as part of the tile manufacturing process. Mixing, weighing, and processing asbestos-containing raw materials created conditions in which airborne fiber concentrations could reach hazardous levels without adequate engineering controls or respiratory protection. Industrial workers generally employed at these facilities were among those with the most sustained and direct fiber exposure.

Installation Exposure: Floor tile installers and general construction laborers routinely cut Excelon tiles to fit room dimensions, edges, and obstructions. Cutting was commonly performed with hand scribes, utility knives, or mechanical saws. Dry-cutting methods in particular could release chrysotile fibers into the breathing zone of workers and others present in enclosed spaces. Plaintiffs alleged that installation activities generated measurable quantities of airborne asbestos fibers under workplace conditions typical of the period.

Abatement and Demolition Exposure: The hazard associated with Armstrong Excelon tile did not end when the product left production. Renovation workers, demolition crews, and maintenance personnel who disturbed existing tile installations — through chipping, grinding, sanding, or mechanical removal — faced exposure to asbestos fibers released from degraded or physically disrupted tile material. AHERA regulations specifically address vinyl asbestos floor tile as a friable or potentially friable asbestos-containing material under certain disturbance conditions, and mandate trained abatement procedures for its removal in regulated facilities.

Bystander and Secondary Exposure: Litigation records document allegations involving individuals who were present in work areas where Excelon tile installation or removal was occurring, as well as family members of workers who may have carried asbestos fibers home on clothing and equipment — a secondary exposure pathway recognized in occupational health literature.

Throughout the period of Excelon’s production and widespread use, OSHA permissible exposure limits for asbestos were substantially higher than current standards. The agency’s subsequent progressive tightening of allowable fiber concentrations, culminating in the current 0.1 fiber per cubic centimeter eight-hour time-weighted average, reflects the scientific consensus that developed regarding the carcinogenic and fibrogenic hazards of asbestos at levels once considered acceptable.

Armstrong World Industries filed for Chapter 11 bankruptcy protection in 2000, citing asbestos-related liability as a primary driver of the reorganization. The company subsequently emerged from bankruptcy; however, unlike some asbestos defendants, Armstrong did not establish a Section 524(g) asbestos personal injury trust as part of its reorganization plan in a manner that created a separately funded claimant trust of the type administered by organizations such as the RAND Institute for Civil Justice has documented across the asbestos trust landscape. As a result, there is currently no Armstrong World Industries asbestos trust fund through which former Excelon tile claimants may file standardized claims.

Individuals diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related diseases following exposure to Armstrong Excelon vinyl asbestos floor tile have pursued legal remedies through civil litigation in the tort system. Plaintiffs alleged in filed cases that Armstrong World Industries knew or should have known of the hazards associated with asbestos-containing products, failed to adequately warn workers and consumers, and continued manufacturing Excelon tile despite available evidence of asbestos-related disease risk.

Because no dedicated Armstrong trust fund exists, legal options for affected individuals and their families typically involve:

  • Direct civil litigation against Armstrong World Industries or its corporate successors
  • Claims against other responsible parties, including asbestos suppliers, co-manufacturers, and contractors who specified or installed Excelon tile in occupational settings
  • Claims against other asbestos trusts if the claimant’s exposure history includes additional asbestos-containing products covered by funded trusts

Anyone with a confirmed asbestos-related diagnosis and a history of occupational or secondary exposure to Armstrong Excelon vinyl asbestos floor tile should consult with an attorney experienced in asbestos litigation to evaluate the full scope of potential legal claims, applicable statutes of limitations, and available compensation pathways. Exposure histories involving multiple products and worksites — common among industrial workers of the mid-twentieth century — may support claims against multiple defendants and trust funds simultaneously.